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ABSTRACT 
Objective: The objective of the proposed work was to study the effect of various formulation and process parameters of solvent casting method on 
the physical and chemical stability of Ketorolac Tromethamine (KT) in the orally dissolving film dosage form.  
Methods: KT-excipient interaction study was carried out both in solid state and by processing samples through the solvent casting technique. The 
samples were evaluated using IR spectroscopy (IR) and X-ray diffractometry (XRD). Solvent casting method was used to prepare KT films using 
different film-forming polymers, and solvents. The drying temperature and pH of the dispersion were also varied to study the effect of these 
parameters on the stability of KT. All the formulations were analysed chemically initially and after one month of storage at 40 °C/75% RH.  
Results: During KT-excipient interaction study in solid state KT was found to be stable. No significant changes were observed in its impurity profile. 
Interaction between different polymers and KT was observed after the solvent casting process as revealed by IR and XRD analysis. The interaction was 
further confirmed in the film formulations upon chemical analysis. The polymers showing interaction with KT in XRD and IR were making it unstable 
chemically and were responsible for its chemical degradation as revealed by chemical analysis. It was also revealed that KT is most stable when 
processed using water as the solvent. KT was found to be stable when processed at a higher temperature and at acidic pH during film formation. It was 
found that chemical stability is more when Polyethylene oxide (PEO) and water under acidic pH are used and films are dried at a higher temperature. 
Conclusion: Both formulation parameters and processing conditions of the solvent casting technique affects the stability of drugs and hence should 
be studied as part of pre-formulation studies while developing orally dissolving films of drugs. 
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Orally disintegrating strips are relatively a new dosage form. These 
are very thin, rectangular, paper-like films that disintegrate quickly 
when kept on the tongue. These are becoming a very popular dosage 
form for special need patient population like pediatric, geriatric, 
dysphagic, mentally challenged and bedridden. Few products are 
already available in the market and many are under development.  
These thin films are prepared using the solvent casting method. 
This method is distinctly different from manufacturing methods of 
other oral solid dosage forms. In the solvent casting method, all 
the ingredients are mixed uniformly in aqueous or hydro-alcoholic 
solvents to form a uniform dispersion of desired consistency. This 
dispersion is then spread in the form of a thin film of uniform 
thickness and dried in the drying chamber. The quantity of 
moisture and exposure to high temperature is significantly more 
in this process as compared to any other manufacturing process, 
like, granulation, tableting, pelletization, coating etc. Due to this, 
physicochemical interactions may take place that may affect the 
stability of the product. This might be the reason that despite 
being very useful dosage form, not many products are being 
launched in the market. 
Ketorolac tromethamine (KT) is a salt of (RS)-5-benzoyl-2,3-
dihydro-1H-pyrrolizine-1-carboxylate with 2-amino-2-
(hydroxymethyl) propane-1,3-diol [1]. It has both anti-inflammatory 
and analgesic activity with the analgesic activity being 800 times 
more potent than aspirin [2]. Degradation behavior of KT has been 
studied by several researchers in the presence of different factors 
like pH, temperature, oxidant, and light. The acidic, basic and neutral 
solution of the drug was found to degrade in hydrolytic, photolytic 
and thermal conditions but the solid form of the drug was found to 
be stable under photolytic condition [2-6]. Study of the literature 
suggests that KT being sensitive molecules may not yield stable film 
formulation when formulated into orally dissolving films using the 
solvent casting technique. 
KT is already available commercially in the form of oral tablets [7], 
solution for injection [8], nasal sprays [9] and ophthalmic solutions 
[10]. Strategies for stabilizing KT in these formulations are already 
established and known. Some film based dosage forms of KT like, 
transdermal patches [11], nanocomposite ophthalmic films [12], 
sublingual films [13], orobuccal films [14] are reported in the 
literature, but none of them reports the effect of formulation and 
process parameters on the stability of KT. 
The proposed work aims to study the effect of various film-forming 
polymers and process parameters of solvent casting method on the 
physical and chemical stability of KT in the orally dispersible film 
dosage form.  
MATERIALS AND METHODS 
Materials 
KT was procured from Symed Labs. Commercial grade excipients 
Hypromellose (HPMC) and Polyethylene oxide (PEO) were 
purchased from Dow Chemicals, Hydroxypropyl cellulose (HPC) was 
from Ruitai and Kollicoat IR from BASF. The plasticizer Propylene 
glycol and antioxidant Butylated hydroxyanisole (BHA) were 
purchased from Finar Limited. All the excipients were stored as 
received under optimum storage conditions until use. 
Methods 
Analytical method 
A complete analysis of impurities was determined using a Shimadzu 
HPLC system and C18 column (250 mm X 4.6 m, 5 μm) (Suprisorb 
ODS-100). The mobile phase was Methanol: Water: Glacial Acetic 
acid (550:440:10) with a flow rate of 1.2 ml/min. The UV detector 
was used at 254 nm. The column temperature was 30 °C. 
Drug-excipient interaction study in the solid state 
In a detailed KT-excipient interaction study, KT was intimately 
mixed with each excipient as per the ratio mentioned in table 1 
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using clean glass mortar and pestle. Each mixture was then divided 
into two portions and placed in glass vials capped with perforated 
aluminum foil and was stored at 40 °C/75% RH for 30 d. The 
mixtures were analyzed for chemical degradation using the HPLC 
method on Day 1 and after completion of studies. The results were 
compared with pure KT stored under similar conditions. Placebos 
for all the samples were also prepared and stored under similar 
conditions [15]. 
 
Table 1: Selected excipients and their ratio 
S. No. Excipient Ratio with KT 
1 HPMC 1:1 
2 HPC 1:1 
3 Kollicoat IR 1:1 
4 PEO 1:1 
5 Propylene glycol 1:0.1 
6 BHA 1:0.1 
 
Drug-polymer interaction study under processing conditions 
To understand the behavior of KT in the presence of various film-
forming polymers during the film forming process, KT was 
processed in the presence of selected film-forming polymers. For 
this, a solution of film-forming polymer/s (table 2) was prepared by 
dissolving about 50 g of polymer/s in about 100 ml of water and 
kept overnight. About 10 g of KT was dissolved in this solution and 
stirred for 15 min. The solution was then dried at 70 °C. The dried 
powders were then pulverized and analyzed using IR spectroscopy 
(Shimadzu FTIR 8101) and X-ray diffractometry (Philips Analytical-
X’Pert PRO). The physical mixtures in a similar ratio were also 
prepared and analyzed for comparing the effect of processing 
conditions on the KT. 
 
Table 2: Compositions of drug and polymer for studying the effect of processing conditions 
S. No. Mixture composition Formulation code 
Physical mixture Processed mixture 
1 KT+HPMC (1:1) KT1A KT1B 
2 KT+HPMC+HPC (1:0.5:0.5) KT2A KT2B 
3 KT+Kollicoat (1:1) KT3A KT3B 
4 KT+PEO (1:1) KT4A KT4B 
5 KT+HPMC+Kollicoat (1:0.5:0.5) KT5A KT5B 
6 KT+HPMC+PEO (1:0.5:0.5) KT6A KT6B 
 
Preparation of KT films using different polymers 
In this study, KT films were prepared using selected film-
forming polymers and their mixtures. Solvent casting method 
was used for preparing these films [16, 17]. Literature revealed 
that KT undergoes degradation under acidic, basic, thermal and 
photolytic conditions. In most cases, the impurity produced is 
because of the oxidation of KT. So, care was taken to prepare a 
neutral solution in the presence of a suitable antioxidant and the 
whole process was carried out in diffused light. In a separate 
study, BHA was found to be a good antioxidant to prevent the 
generation of oxidation induced impurities. Therefore, BHA was 
added to all the formulations. 
Table 3 gives the composition of each formulation. The film-forming 
polymer was dissolved in water and left overnight to obtain a 
homogenous mixture. Propylene glycol, KT and BHA were added into 
this mixture and stirred with the help of mechanical stirrer at a speed of 
3000 rpm for 15 min. The solution was then degassed with the help of 
the vacuum. The casting dispersion so obtained was then uniformly cast 
on a polyester sheet with the help of a doctor’s blade to a uniform 
thickness. The films were then dried in the drying chamber at 70 °C for 
15 to 20 min. All the operations were carried out under diffused light. 
The films so obtained were cut into suitable sizes and packed in triple 
layer aluminum pouches, sealed and stored at 40 °C/75% RH for 30 d. 
The films were evaluated initially and after a period of 30 d for the 
quantitative estimation of impurities. 
 
Table 3: Film formulations of KT with the selected film-forming polymer/s 
S. No. Ingredients Composition in percent 
F1 F2 F3 F4 F5 F6 
1 Ketorolac Tromethamine 20 20 20 20 20 - 
2 HPMC 56 - - - - - 
3 HPMC+HPC (1:1) - 56 - - - - 
4 Kollicoat IR - - 56  - - 
5 PEO - - - 56 - - 
6 HPMC+Kollicoat IR (1:1) - - - - 56 - 
7 HPMC+PEO (1:1) - - - - - 56 
8 Propylene Glycol 20 20 20 20 20 - 
9 BHA 4 4 4 4 4 - 
10 Water qs qs qs qs qs qs 
 
Preparations of KT films using different solvents 
To investigate the role of solvents in the stability of KT, Formulation 
F6 was prepared using different casting solvents as given in table 4. 
Method of preparation was the same as given in section 2.4, only 
water was replaced. If the quantity of IPA is increased beyond 40% 
in the solvent, good quality films were not obtained. This finding was 
in accordance with our earlier findings [18]. The films so obtained 
were cut, packed, sealed and stored at 40 °C/75% RH for 30 d.  
The films were evaluated initially and after a period of 30 d for the 
determination of impurities. 
Sapkal et al. 
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Table 4: Film formulations of KT prepared using different solvent systems 
S. No. Casting solvent Formulation code 
1 Water F6 
2 Water: IPA (80:20) F6A 
3 Water: IPA (70:30) F6B 
4 Water: IPA (60:40) F6C 
 
Preparation of KT films using different drying temperatures  
To evaluate the role of drying temperature on the stability, 
formulation F6 was formulated using the method described in 
section 2.4 and was dried at 70 °C (F6), 50 °C (F6D) and 40 °C (F6E). 
The films so obtained were cut, packed, sealed and stored at 40 
°C/75% RH for 30 d. The films were evaluated initially and after a 
period of 30 d for chemical degradation. 
Preparation of KT films using different pH conditions 
To evaluate the role of pH in the stabilization of KT films, pH of the 
dispersion was adjusted to 3 (F6 pH3), 5 (F6 pH5) and 9 (F6 pH9) by 
adding 0.1 M HCl or 0.1 M NaOH. The dispersions were then 
processed as mentioned in section 2.4 and casted films were stored 
at 40 °C/75% RH for 30 d. The films were evaluated initially and 
after a period of 30 d for the determination of impurities. 
RESULTS AND DISCUSSION  
In the drug excipient compatibility studies the objective was to study 
the effect of temperature and moisture on the stability of KT in the 
physical mixtures with the various film-forming polymers. No 
impurities were detected after storing the physical mixtures at 40 
°C/75% RH conditions. This establishes that KT is fairly stable in 
solid state conditions with the selected polymers.  
The purpose of conducting KT excipient compatibility study was 
to study the effect of processing conditions on KT in presence of 
different film forming polymers. The effects were studied using 
IR spectroscopy and X-ray diffractometry. IR spectra of pure KT 
revealed characteristic peaks depicting the functional groups 
like amino, hydroxyl, carbonyl, etc. present in the KT structure 
(table 5). 
 
Table 5: Characteristic peaks of pure KT 
S. No. Functional group  Peak no. 
1 O-H Stretch  3449 
2 N-H stretch  3345 
3 C-H Stretch 2980 
4 C=O stretch  1593, 1614 
5 C=C Stretch  1566, 1545 
6 O-H N-H Bending 1492, 1470 
7 C-H bending 1381, 1310 
8 C-N Stretch  1275 
9 Carboxylic O-H bending  1431 
10 Alcoholic C-O stretch  1088, 1045 
11 =C-H In-plane bending  895, 799 
12 =C-H out of plane bending  772,723 
 
The IR spectra of KT processed (fig. 1) in the presence of HPMC 
showed the shifting of some peaks. The sharp N-H peak at 3345 cm-1 
and C-H stretch at 2980 cm-1 was broadened and lowered in 
intensity indicating that these groups are interacting with HPMC. 
The O-H peak at 3449 cm-1 got merged with the N-H peak. There is a 
possibility of Hydrogen bonding between the KT OH and HPMC 
hydroxyl groups. The C=O stretch was slightly shifted from 1593 to 
1591 cm-1 and it got merged with carboxylic C=C stretch at 1566 cm-
1suggesting both of these functional groups getting affected by the 
interaction. The alcoholic C-O stretch at 1045 cm-1 was found to be 
broadened. A significant change in the region from 1600-1000 cm-
1
After processing KT with PEO, no significant changes were observed in 
IR spectra. Except that O-H stretch was merged with N-H stretch, rest 
of the peaks were shifted slightly to lower wave numbers in the same 
way as with Kollicoat IR. The C-H stretch exhibited a sharp peak with 
decreased intensity. So, it can be concluded that KT interacts with PEO 
in a different mechanism than that of other polymers. 
In the presence of a mixture of HPMC and Kollicoat IR, the IR spectra 
of the processed sample showed mixed changes that were observed 
in the presence of individual polymers. N-H peak was unaffected 
while the O-H peak got merged with the N-H peak. Peaks of carbonyl 
groups in the area from 1600-1000 were slightly shifted to lower 
frequencies indicating that hydroxyl groups of tromethamine and 
carboxylic groups are participating in the interaction. This 
interaction is affecting the rest of the groups. 
IR spectra of both KT6B reveals that PEO when present with HPMC 
is able to protect N-H groups from interactions. The C-H stretch 
shifted to a lower frequency. The remaining peaks exhibited minor 
negligible variation. To summarize, PEO shows little interactions 
with KT in comparison to other film-forming polymers. 
was observed suggesting the interaction of functional groups of KT 
with HPMC. 
When the combination of HPMC and HPC was used, the processing 
resulted in significant changes in the peak shape and peak position. 
The changes in the spectra of KT2B resembled with that of KT1B 
indicating similar interactions occurring between KT and HPMC and 
HPC. This is due to similarity in the structures of both the polymers. 
KT in the presence of Kollicoat showed a reduction in peak intensity 
in the N-H stretch, while C-H stretch was not affected. Additionally, 
O-H peak merged with the N-H peak. Both carbonyl and C=C stretch 
were slightly shifted to the lower wavenumbers which may be due 
to the hydrogen bonding with the polymer. Alcoholic C-O bend was 
also affected. Except for OH peaks, rest of the peaks retained their 
shape and were shifted to slightly lower intensities. 
The XRD diffractograms (fig. 2) of physical mixtures of KT with 
various excipients revealed that the strong crystalline nature of KT 
remained mostly intact when processed using selected film-forming 
polymers. The comparison of XRD diffractograms of the physical 
mixture of KT and HPMC with that of the processed powder showed 
the drastic change (fig. 2). The powder after processing was 
completely amorphous and no characteristic peaks of KT were 
observed. KT is water soluble which means it dissolves during 
dispersion formation and forms strong hydrogen bonds with HPMC. 
Therefore, while drying KT remains in the bonded form with HPMC 
as revealed by IR spectra of the processed powder and exists in the 
amorphous form as seen in XRD diffractogram [19, 20]. 
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Fig. 1: IR spectra of pure KT, physical and processed mixtures of KT with excipients 
 
The mixture of HPMC and HPC behaves differently than HPMC alone. 
The XRD diffractogram revealed retention of crystallinity of KT after 
processing and many characteristic peaks were observed in the 
processed sample. The mixture of KT and Kollicoat retained the 
crystalline nature of KT but some diffused peaks could also be seen 
indicating a mixture of crystalline and amorphous nature of both 
drug and excipient. The Processed mixture of KT with PEO exhibited 
both sharp and diffused peaks to the same extent indicating mixed 
product characteristics. KT, HPMC, and Kollicoat processed mixture 
also exhibited mixed characteristics, however, with the processed 
mixture of KT, HPMC and PEO nearly the same characteristics were 
seen as with their physical mixture. These findings revealed that 
when processed with HPMC, KT completely gets converted to 
amorphous form and with PEO crystalline form is retained. PEO also 
help KT to retain its crystalline structure even in present in 
combination with HPMC. 
  
 
Fig. 2: XRD diffractograms of physical and processed mixtures of KT with excipients 
 
The chemical analysis of KT films with different film-forming polymers 
revealed the effect of individual polymer on the chemical stability of KT. 
The initial impurities for the KT films were well below the specified limit 
(table 6). After one month period at 40 °C/75% RH, KT films containing 
HPMC showed a drastic increase in total impurity level. This could be 
due to an interaction of HPMC with functional groups of KT, as revealed 
Sapkal et al. 
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in IR spectroscopy. Further, complete amorphization of KT in presence 
of HPMC (as revealed by XRD) indicates that the amorphous form of KT 
is chemically unstable. Amorphous forms of KT in the presence of 
Hydroxypropyl-β-cyclodextrin, chitosan and gelatin are reported before 
[21, 22], but no studies on its chemical stability are reported. Least 
impurity level was observed with PEO, thus making it the most inert 
polymer followed by Kollicoat, but films produced by both of these 
polymers were not of desirable quality. F3 was brittle with poor folding 
endurance and F4 was sticky and tacky. The surface removal of both of 
these films was not good. The combination of HPMC with PEO had a 
lower impurity level than that of the combination of HPMC with 
Kollicoat. The reason for this must be the retention of crystallinity due to 
the presence of PEO. PEO must have prevented cross-linking of KT 
functional groups with HPMC by replacing some HPMC with itself during 
the polymerization process. Therefore, it was decided to continue 
further studies with F6. 
 
Table 6: Impurity of KT with different polymers 
Formulation 
code 
F1 F2 F3 F4 F5 F6 




















































Data are given in mean±SD, number of experiments (n): 3 
 
It was thought that as KT is soluble in water during the solvent 
casting process, evaporation of water must be leading to re-
precipitation of KT which precipitates in amorphous form. In the 
previous study with different film-forming polymers, it was revealed 
that the polymers that exhibited little interaction in IR and XRD 
yielded stable films. Therefore, it was decided to use hydro-alcoholic 
solvents in various concentrations to reduce the solubility of KT. The 
limit of impurities for KT films prepared using water alone and in 
combination with a non-aqueous solvent were also well below the 
specified limit initially (table 7). After one month at 40 °C/75% RH, 
impurity level increased with an increase in the amount of non-
aqueous solvent which, however, remained almost constant after 
certain water: non-aqueous solvent ratio. This indicates that 
alcoholic solvents act as reaction initiators for chemical degradation 
reactions of KT and therefore, water maintains the stability of KT in 
films dosage form better than non-aqueous solvents. 
 
Table 7: Impurity in KT films using different solvents 
Formulation code F6 F6A F6B F6C 
Time points Initial 1 Mo Initial 1 Mo Initial 1 Mo Initial 1 Mo 
Unknown maximum impurity 
(NMT 0.1%) 
ND 0.077±0.01 0.05±0.00 0.26±0.05 0.006±0.00 0.504±0.07 0.007±0.00 0.22±0.05 
Total impurities (NMT 1.0%) 0.056±0.00 0.687±0.05 0.045±0.00 2.28±0.08 0.06±0.00 2.656±0.13 0.054±0.00 2.428±0.14 
Data are given in mean±SD, number of experiments (n): 3 
 
Since temperature plays a very important role in chemical reactions, KT 
films were dried at different temperatures. As expected, the initial 
impurity level was found to be within limits at all temperatures (table 8). 
However, the impurity level after one month period at 40 °C/75% RH 
was found to be in increasing order with a decrease in casting 
temperature. Temperature-dependent degradation of KT has been 
reported earlier but that was done only in powder blends and no effect 
of processing conditions was reported [23]. This could be due to the 
exposure of KT for longer durations at lower temperatures as compared 
to a shorter duration at the higher temperature. 
  
Table 8: Impurity in KT films prepared at different temperatures 
Formulation code F6 (70 °C) F6D (50 °C) F6E (40 °C) 
Time points Initial 1 Mo Initial 1 Mo Initial 1 Mo 
Unknown maximum impurity (NMT 0.1%) ND 0.077±0.01 ND 0.198±0.03 0.006±0.00 0.224±0.06 
Total impurities (NMT 1.0%) 0.056±0.00 0.687±0.05 0.06±0.00 1.89±0.09 0.055±0.00 2.28±0.14 
Data given in mean±SD, number of experiments (n): 3 
 
Literature reveals that KT exhibits pH-dependent degradation, 
therefore the effect of pH on stability of KT films was studied by 
preparing casting dispersion at different pH. KT films prepared at 
different dispersion pH of 3, 5 and 9 had initial impurities within 
limits (table 9). However, these initial impurities decreased with an 
increase in pH. The dispersion with pH 3 showed the highest initial 
impurity. After a period of one month, however, impurities at pH 5 
were found to be the highest while at pH 3 it remained the same. 
Lower pH can thus be considered to keep KT stable in films as 
reported earlier [23]. 
 
Table 9: Impurity in KT films prepared at different pH 
Formulation code F6 pH3 F6 pH5 F6 pH9 
Time points Initial 1 Mo Initial 1 Mo Initial 1 Mo 
Unknown maximum impurity (NMT 0.1%) 0.131±0.07 0.131±0.07 0.108±0.05 0.338±0.03 0.078±0.00 0.121±0.01 
Total impurities (NMT 1.0%) 0.345±0.05 0.345±0.07 0.219±0.08 0.870±0.09 0.193±0.05 0.402±0.06 
Data given in mean±SD, number of experiments (n): 3 
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KT was found to be stable in the presence of excipients during solid-state 
excipient compatibility studies. It was found that the stability of KT is 
affected by the nature of film-forming polymers. HPMC showed higher 
interaction affecting both physical and chemical stability of KT. PEO, on 
the other hand, was found to be the most inert polymer maintaining the 
stability of KT efficiently followed by Kollicoat. Water as a solvent system 
maintained the ability of KT in films as compared to its combination with 
a non-aqueous solvent. Higher drying temperatures reduced the travel 
time during casting operation which in turn lowered the degradation 
process. It can also be said that maintaining an acidic pH during the 
formulation stages gives more stable KT films. In conclusion, both 
formulation and process parameters affect the stability of KT in an orally 
dissolving film dosage form. 
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